Government report reveals weak spots in functioning of Indian pharma industry

Staff crunch, transparency issues and outdated trial methods plague monitoring activity

Faulty formula

New drug pricing policy proposes bringing all essential medicines under price control, but makes them expensive

Jan Aushadhi Stores fail to take off

Very few visit governmentÔÇÖs generics retail outlets

Pesticides lobby’s coup

Krishi Bhavan supports endosulfan companies; Kerala protests

15 doctors went on foreign jaunt sponsored by pharma company, says Lok Sabha member

Doctors and pharma company deny charges

Pharma companies determine what patients buy

Dow in the dumps?

Choking access to drugs

Drug prices are likely to increase as rich countries and their pharma companies squeeze Indian generics out of the market. How can India’s …

Fall of a premier institute

Amid funds siphoning allegations, future of National Institute of Pharma Education seems bleak